J&J’s quarter: stronger sales, weaker earnings—but a higher outlook. 👀
Q3 sales rose 5.9% to US$25.4B, while adjusted EPS fell 7.5% to US$2.59. Reported EPS was just US$0.09, reflecting a special talc-litigation charge and deal impacts.
Yet J&J raised its 2026 adjusted EPS guidance to US$11.05–11.15.
My takeaway: revenue growth is only part of the story. Earnings quality and the price you pay matter too.
Source: J&J, Oct. 13, 2026. Adjusted figures are non-GAAP; guidance isn’t guaranteed.
#JNJ #BlushInWealth #Investing
